A study by Yu et al. [40] suggested the use of PDE inhibitors to indirectly inhibit YAP pathway by activation of the Hippo pathway in a cAMP-PKA -dependent manner in the MDA-MB-231 human breast adenocarcinoma cell line. This evidence concerns the gene ALDH7A1 and breast adenocarcinoma.